Search For "drugs controller general of india"
Six vaccines currently undergoing clinical trials in India
Updated : 5 years, 3 months ago IST
New Delhi [India], December 15 (ANI): Informing that the Drugs Controller General of India has granted clearance for the clinical trials of one more candidate vaccine from India, NITI Aayog Member (Health) Dr VK Paul on Tuesday said six vaccines are currently undergoing clinical trials in
Read More
DCGI expert panel asks SII, Bharat Biotech to provide more safety, efficac
Updated : 5 years, 3 months ago IST
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
Read More
Reports that Centre rejected SII, Bharat Biotech's emergency use authorisa
Updated : 5 years, 3 months ago IST
New Delhi [India], December 9 (ANI): The Ministry of Health and Family Welfare on Wednesday dismissed the media report about the rejection of Serum Institute India (SII) and Bharat Biotech's emergency use authorisation of COVID vaccine and called it "fake".
Read More
Bharat Biotech applies for emergency use authorisation for its COVID-19 va
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): Bharat Biotech on Monday applied for emergency use authorisation for its indigenously developed COVID-19 vaccine 'Covaxin' to Drugs Controller General of India (DCGI), officials said.
Read More
Serum Institute of India seeks emergency use authorisation for its COVID-1
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country.
Read More
Pfizer becomes first pharma company in India to seek emergency use nod for
Updated : 5 years, 3 months ago IST
New Delhi [India], December 6 (ANI): Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country.
Read More
DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19 vaccine
Updated : 5 years, 4 months ago IST
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Read More
ICMR issues advisory on CRISPR technology-based SARS CoV-2 test
Updated : 5 years, 4 months ago IST
New Delhi [India], October 23 (ANI): The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General of India for COVID-19 detection.
Read More
Expert panel recommends DCGI to permit Dr Reddy's Lab to conduct phase 2,3
Updated : 5 years, 5 months ago IST
New Delhi [India], October 17 (ANI): The expert committee of Drugs Controller General of India (DCGI) on Friday recommended granting permission to Dr Reddy's Laboratories for conducting phase 2 clinical trials of Russian COVID-19 vaccine candidate, Sputnik V, in India, government officials s
Read More
Dr Reddy's Lab submits revised protocol to DCGI to conduct phase 2,3 clini
Updated : 5 years, 5 months ago IST
New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised application to the Drugs Controller General of India (DCGI) seeking his approval to conduct phase 2 and 3 clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a governm
Read More
DCGI directs Dr Reddy's lab to furnish fresh protocol to seek approval for
Updated : 5 years, 5 months ago IST
New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert panel has directed the pharma giant Dr Reddy's Laboratories (DRL) to submit a revised protocol for performing phase 2,3 clinical trials of the Russian COVID-19 vaccine (Sputnik
Read More
Dr Reddy's Laboratories seeks DCGI permission to conduct Phase III trials
Updated : 5 years, 5 months ago IST
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia
Read More